Adocia Launches First-In-Man Clinical Study Of BioChaperone® Glucagon

ADOCIA a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced today the initiation of a Phase 1 study of BioChaperone® Glucagon, its aqueous formulation of human glucagon. The BioChaperone proprietary technology enables the solubilization and stabilization of human glucagon at neutral pH.

Details:
businesswire.com/news/home/20170531006231/en/Adocia-Launches-First-in-Man-Clinical-Study-BioChaperone%C2%AE-Glucagon

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: